Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1991 | 12-1990 | 03-1990 | 12-1989 | 03-1989 | |
| Operating Expenses | 1,800 | 0 | 0 | 0 | 0 |
| Operating Income | -1,800 | N/A | N/A | N/A | N/A |
| Pre-tax Income | -1,800 | 0 | 0 | 0 | 0 |
| Net Income Continuous | -1,800 | N/A | N/A | N/A | N/A |
| Net Income | $-1,800 | $N/A | $N/A | $N/A | $N/A |
| EBITDA(a) | $-1,800 | $N/A | $N/A | $N/A | $N/A |